It takes the average reader 8 hours and 30 minutes to read Cancer Genomics by Moamen Bydoun
Assuming a reading speed of 250 words per minute. Learn more
Breast cancer is the most common cancer in women worldwide and the second leading cause of cancer deaths. Although early diagnosis, outcome prediction and treatment options are the ultimate objectives when assessing breast cancer patients, the methodology behind this clinical assessment varies and has gradually evolved from using standard clinical criteria into incorporating high-throughput genome-wide analysis. Early methods involved evaluating tumor size and spread as well as histological assessment (tumor grade). Later, the expression of hormone/growth receptors (ER, PR, and HER2) was added to the standard stratification of breast cancer patients. More recently, molecular approaches, which are based on the expression of a well-defined set of genes, have subdivided patients into five clinically relevant subtypes which not only predict prognosis and dictate treatment choice but also complement standard assessment. The advent of genome-wide analysis has produced the most robust classification system of breast cancers by coupling specific genetic aberrations (single nucleotide mutations and gene copy number variations) with gene expression profiles. Although these genome-wide approaches offer a promising future for breast cancer prognosis and treatment options, they are still not clinically feasible for standard population-based screening. Nonetheless, these approaches are becoming faster and more reliable in understanding the molecular architecture of breast cancer and are slowly paving the way towards personalized treatments which are tailored to individual patients. In the light of a rapidly evolving field of breast cancer genomics, this chapter highlights key standard and upcoming approaches for diagnosis, prognosis and treatment and discusses the feasibility of genome-oriented personalized treatments.
Cancer Genomics by Moamen Bydoun is 510 pages long, and a total of 127,500 words.
This makes it 172% the length of the average book. It also has 156% more words than the average book.
The average oral reading speed is 183 words per minute. This means it takes 11 hours and 36 minutes to read Cancer Genomics aloud.
Cancer Genomics is suitable for students ages 12 and up.
Note that there may be other factors that effect this rating besides length that are not factored in on this page. This may include things like complex language or sensitive topics not suitable for students of certain ages.
When deciding what to show young students always use your best judgement and consult a professional.
Cancer Genomics by Moamen Bydoun is sold by several retailers and bookshops. However, Read Time works with Amazon to provide an easier way to purchase books.
To buy Cancer Genomics by Moamen Bydoun on Amazon click the button below.
Buy Cancer Genomics on Amazon